LataMed AI Evaluates Insurance Integration with Vertice Seguros to Expand Digital Healthcare Ecosystem

LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that it has begun a strategic evaluation process with Vertice Seguros, a Venezuelan insurance provider, to explore integrating insurance products and healthcare technology services within its expanding digital healthcare ecosystem. The initiative seeks to evaluate a framework where life and health insurance offerings from Vertice Seguros could become accessible through LataMed AI's platforms, while also enabling Vertice Seguros clients to access LataMed AI's telehealth, care coordination, analytics, and AI-enabled solutions.

Management believes this proposed collaboration could create complementary commercial opportunities for both organizations by expanding customer reach, increasing healthcare accessibility, enhancing patient engagement, and supporting broader adoption of technology-enabled healthcare and financial protection solutions throughout Latin America. Preliminary operational, technical, and commercial evaluations are underway to assess user onboarding, platform integration, regulatory considerations, and potential service deployment models. These activities aim to determine the feasibility and scalability of a broader strategic relationship.

Dr. Kevin Rodan Levy, CEO of LataMed AI, stated: "Our vision is to create a more connected healthcare ecosystem where technology, care delivery, and financial protection solutions work together to improve accessibility and outcomes. We believe this evaluation process with Vertice Seguros represents an opportunity to explore how healthcare technology services and insurance solutions can be combined within a unified digital platform."

The company emphasizes that healthcare accessibility extends beyond care delivery to include financial protection solutions. By combining technology services with insurance access, LataMed AI aims to support greater patient engagement and improve long-term healthcare outcomes in underserved markets. This evaluation aligns with the company's broader strategy of developing an integrated ecosystem combining AI, telehealth infrastructure, analytics, care coordination, pharmacy connectivity, and emergency response capabilities.

Any definitive arrangement would remain subject to successful completion of evaluations, negotiation of final terms, regulatory considerations, and execution of definitive agreements. The company intends to provide updates as material developments occur. For more information, visit https://latamed.ai or review SEC filings at www.sec.gov.